Table 2 Common stroke scale test and blood biomarker detection results.
Placebo group (n = 20) | Treatment group (n = 22) | Main effect of time | Main effect of group | Interaction | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Baseline | 2 weeks later | Baseline | 2 weeks later | F value | P value | F value | P value | F value | P value | |
NIHSS | 5.85(3.28) | 3.65(2.80) | 6.64(3.09) | 3.23(2.41) | 0.079 | 0.780 | 0.079 | 0.780 | 5.402 | 0.026* |
Barthel | 68.50(26.01) | 80.75(19.49) | 66.82(26.07) | 67.62(25.74) | 0.563 | 0.458 | 0.026 | 0.872 | 1.661 | 0.205 |
mRS | 2.80(1.28) | 2.00(1.33) | 3.18(1.18) | 1.73(1.32) | 2.069 | 0.159 | 0.043 | 0.837 | 4.038 | 0.052 |
SSQOL | 147.35(41.47) | 189.40(37.97) | 125.05(43.63) | 204.05(44.27) | 1.466 | 0.234 | 0.024 | 0.877 | 9.755 | 0.003** |
Infarct volume | 43280.70 (26358.07) | 48388.95 (29839.52) | 41005.36 (20465.21) | 38572.29 (20386.29) | 1.470 | 0.212 | 0.039 | 0.845 | 1.365 | 0.250 |
Fibrinogen | 2.83(0.50) | 2.75(0.52) | 3.26(0.99) | 9.26(1.12) | 0.116 | 0.736 | 2.506 | 0.122 | 0.042 | 0.838 |
Hematocrit | 39.09(4.72) | 39.54(4.53) | 39.70(4.41) | 38.53(3.54) | 3.978 | 0.054 | 0.001 | 0.980 | 4.601 | 0.039* |
Total cholesterol | 5.00(1.39) | 4.67(0.99) | 4.64(1.22) | 4.34(0.98) | 2.222 | 0.145 | 2.205 | 0.333 | 0.02 | 0.888 |
Triglyceride | 1.81(1.99) | 1.92(1.97) | 1.91(1.00) | 1.85(0.95) | 0.013 | 0.909 | 0.131 | 0.719 | 0.948 | 0.336 |
Low-density lipoprotein | 3.00(0.90) | 2.77(0.67) | 2.76(0.96) | 2.54(0.68) | 0.900 | 0.349 | 1.572 | 0.218 | 0.005 | 0.942 |
High-density lipoprotein | 1.41(0.57) | 1.22(0.25) | 1.10(0.20) | 1.17(0.27) | 2.406 | 0.129 | 4.081 | 0.051 | 2.056 | 0.160 |
